{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

420 with CNW — New Report Shows Illicit Marijuana is Being Sold as Hemp in Missouri

December 4, 2025A new report from the Missouri Cannabis Trade Association says many retailers that advertise legal hemp products are instead selling cannabis products with high THC levels. The group’s findings come from laboratory tests on 55 products purchased at gas stations, smoke shops, and stores that market themselves as hemp or CBD sellers.


TechMediaBreaks – BluSky AI Inc. (BSAI) Pushing the Boundaries of AI Infrastructure with Neocloud and SkyMod Technology

December 4, 2025As tech giants pour billions into traditional data center expansion, BluSky AI (OTC: BSAI) is uniquely positioned with its innovative Neocloud platform and modular SkyMod technology. “BluSky AI is focused to democratize access to enterprise-grade AI infrastructure through a fundamentally different approach, delivering compute power in months rather than years,” reads a recent article.


TechMediaBreaks – Parler Technologies, Inc. Launches Regulation D 506(c) Offering Ahead of Planned 2026–2027 Uplisting

December 4, 2025Parler Technologies has initiated a Regulation D, Rule 506(c) private placement to raise up to $50 million, with the option to increase to $100 million, ahead of a planned Nasdaq or NYSE public offering targeted for late 2026 or early 2027. Managed by Digital Offering, the raise allows accredited investors to participate in Parler’s rebuilt, fully sovereign technology ecosystem, which includes Triton Cloud, Edgecast CDN, PlayTV, Kyvo, Cartix, and ParlerNews operating on an integrated blockchain protocol layer.


InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) identifies Biomarker Signature Predicting Sensitivity to IV Sapu003

December 4, 2025Oncotelic Therapeutics (OTCQB: OTLC), reports that its 45% owned joint venture, Sapu Nano, has identified a High-RICTOR/Low-RPTOR molecular signature that predicts tumor sensitivity to Sapu003, the company’s intravenous Deciparticle(TM) formulation of everolimus. The biomarker framework, to be presented at the 2025 San Antonio Breast Cancer Symposium, is based on analysis of more than 9,000 tumor samples across 20 cancer types and represents the first prospective selection strategy for IV everolimus.


AINewsBreaks – MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Featured in MiningNewsWire Editorial on Rising Energy Demand and Natural Hydrogen

December 4, 2025This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) announces its inclusion in a MiningNewsWire editorial exploring how surging global electricity demand — driven by rapidly expanding AI and data-center power consumption — is creating urgent need for new baseload energy solutions.